Fitness and the development of atrial fibrillation

Circulation

Volumn 131, Issue 21, 2015, Pages 1821-1823

  Bhatt, Advay G ^a   Monahan, Kevin M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Editorials; Exercise tolerance

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN ANTAGONIST; ANTIOXIDANT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ION CHANNEL;

AGE; ATRIAL FIBRILLATION; BLOOD PRESSURE REGULATION; CALORIC INTAKE; CALORIC RESTRICTION; CARDIOMETABOLIC RISK; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; CATHETER ABLATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; EATING HABIT; EDITORIAL; ELECTROPHYSIOLOGY; ENDURANCE TRAINING; EXERCISE TEST; FIBROSIS; FOLLOW UP; GLYCEMIC CONTROL; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FLUTTER; HEART ATRIUM REMODELING; HEART FUNCTION TEST; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; INFLAMMATION; LIFESTYLE MODIFICATION; METABOLIC EQUIVALENT; NONHUMAN; OBESITY; OXIDATION; OXIDATIVE STRESS; PHYSICAL ACTIVITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; RISK REDUCTION; SEDENTARY LIFESTYLE; SINUS RHYTHM; SLEEP DISORDERED BREATHING; SURVIVAL; VALVULAR HEART DISEASE; WEIGHT CONTROL; WEIGHT GAIN; WEIGHT REDUCTION; FEMALE; FITNESS; MALE;

ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; PHYSICAL FITNESS;

EID: 84936164546     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.016596     Document Type: Editorial

References (21)

1. Magnani JW, Rienstra M, Lin H, Sinner MF, Lubitz SA, McManus DD, Dupuis J, Ellinor PT, Benjamin EJ. Atrial fbrillation: current knowledge and future directions in epidemiology and genomics. Circulation. 2011;124:1982-1993. doi: 10.1161/CIRCULATIONAHA.111.039677.
2. Rienstra M, McManus DD, Benjamin EJ. Novel risk factors for atrial fbril-lation: useful for risk prediction and clinical decision making? Circulation. 2012;125:e941-e946. doi: 10.1161/CIRCULATIONAHA.112.112920.
3. Predel HG. Marathon run: cardiovascular adaptation and cardiovascular risk. Eur Heart J. 2014;35:3091-3098. doi: 10.1093/eurheartj/eht502.
4. O'Keefe JH, Patil HR, Lavie CJ, Magalski A, Vogel RA, McCullough PA. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc. 2012;87:587-595. doi: 10.1016/j.mayocp.2012.04.005.
5. Burstein B, Nattel S. Atrial fbrosis: mechanisms and clinical relevance in atrial fbrillation. J Am Coll Cardiol. 2008;51:802-809. doi: 10.1016/j.jacc.2007.09.064.
6. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fbrillation: mechanisms and implications. Circ Arrhythm Electrophysiol. 2008;1:62-73. doi: 10.1161/CIRCEP.107.754564.
7. Nishida K, Datino T, Macle L, Nattel S. Atrial fbrillation ablation: translating basic mechanistic insights to the patient. J Am Coll Cardiol. 2014;64:823-831. doi: 10.1016/j.jacc.2014.06.1172.
8. Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ, Morton JB, Sanders P, Kalman JM. Long-term effects of catheter ablation for lone atrial fbrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm. 2012;9:473-480. doi: 10.1016/j.hrthm.2011.11.013.
9. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfnkle M, Yusuf S, Connolly SJ. Prevention of atrial fbrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol. 2005;45:1832-1839. doi: 10.1016/j.jacc.2004.11.070.
10. Swedberg K, Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Shi H, Vincent J, Pitt B; EMPHASIS-HF Study Investigators. Eplerenone and atrial fbrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. J Am Coll Cardiol. 2012;59:1598-1603. doi: 10.1016/j.jacc.2011.11.063.
11. Rahimi K, Emberson J, McGale P, Majoni W, Merhi A, Asselbergs FW, Krane V, Macfarlane PW; PROSPER Executive. Effect of statins on atrial fbrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. BMJ. 2011;342:d1250.
12. Dimitri H, Ng M, Brooks AG, Kuklik P, Stiles MK, Lau DH, Antic N, Thornton A, Saint DA, McEvoy D, Antic R, Kalman JM, Sanders P. Atrial remodeling in obstructive sleep apnea: implications for atrial fbrillation. Heart Rhythm. 2012;9:321-327. doi: 10.1016/j.hrthm.2011.10.017.
13. Ng C Y, Liu T, Shehata M, Stevens S, Chugh SS, Wang X. Meta-analysis of obstructive sleep apnea as predictor of atrial fbrillation recurrence after catheter ablation. Am J Cardiol. 2011;108:47-51. doi: 10.1016/j. amjcard.2011.02.343.
14. Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, Kramer DB, Zimetbaum PJ, Buxton AE, Josephson ME, Anter E. Treatment of obstructive sleep apnea reduces the risk of atrial fbrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013;62:300-305. doi: 10.1016/j.jacc.2013.03.052.
15. Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, Mahajan R, Kuklik P, Zhang Y, Brooks AG, Nelson AJ, Worthley SG, Abhayaratna WP, Kalman JM, Wittert GA, Sanders P. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fbrilla-tion. Heart Rhythm. 2013;10:90-100. doi: 10.1016/j.hrthm.2012.08.043.
16. Mahajan R, Brooks A, Manavis J, Wood J, Finnie J, Sameul C, Lau D, Selvanayagam J, Roberts-Thomson K, Sanders P. Atrial fbrillation and obesity: impact of weight reduction on the atrial substrate. Heart Lung Circ. 2013;22:S1-S2.
17. Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, Lorimer MF, Lau DH, Antic NA, Brooks AG, Abhayaratna WP, Kalman JM, Sanders P. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fbrillation: a randomized clinical trial. JAMA. 2013;310:2050-2060. doi: 10.1001/jama.2013.280521.
18. Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, Alasady M, Hanley L, Antic NA, McEvoy RD, Kalman JM, Abhayaratna W P, Sanders P. Aggressive risk factor reduction study for atrial fbril-lation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64:2222-2231. doi: 10.1016/j.jacc.2014.09.028.
19. Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, Al-Mallah MH. Cardiorespiratory ftness and risk of incident atrial fbrillation: results from the Henry Ford Exercise Testing (FIT) Project. Circulation. 2015;131:1827-1834.
20. Anné W, Willems R, Van der Merwe N, Van de Werf F, Ector H, Heidbüchel H. Atrial fbrillation after radiofrequency ablation of atrial futter: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics. Heart. 2004;90:1025-1030. doi: 10.1136/hrt.2003.023069.
21. Williams PT. Physical ftness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc. 2001;33:754-761.